stockrowPulmonx Corporation (LUNG) vs Zomedica Corp. (ZOMDF)
- Pulmonx Corporation LUNG 2.53 −1.17%
- Zomedica Corp. ZOMDF 0.09 0.00%
Pulmonx Corporation and Zomedica Corp. are both Medical Devices companies. Pulmonx Corporation is the larger, with a market value of $111.5M against $95.4M — 1.2× the size. Zomedica Corp. grew revenue faster over the last twelve months: 31.3% against −3.15%. Zomedica Corp. has the higher net margin (−41.4% vs −47.9%) and the higher return on invested capital (−17.1% vs −129.9%). Across the 17 metrics below, Zomedica Corp. leads on 10 and Pulmonx Corporation on 7.
Valuation
Profitability
| Metric | LUNG | ZOMDF | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.42% | 63.96% | 57.76% |
| Operating margin | (44.39%) | (45.43%) | (15.07%) |
| Net margin | (47.93%) | (41.35%) | (14.45%) |
| Free cash flow margin | (28.85%) | (34.81%) | (3.88%) |
| Return on equity | (90.31%) | (14.28%) | (10.35%) |
| Return on assets | (34.25%) | (13.01%) | (17.26%) |
| Return on invested capital | (129.86%) | (17.12%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack